| Literature DB >> 17208299 |
Anne E Lockyer1, Jennifer N Spinks, Anthony J Walker, Richard A Kane, Leslie R Noble, David Rollinson, Emmanuel Dias-Neto, Catherine S Jones.
Abstract
Biomphalaria glabrata is the major intermediate snail host for Schistosoma mansoni, one of the important schistosomes infecting man. Much remains to be discovered concerning specific molecules mediating the defence events in these intermediate hosts, triggered by invading schistosomes. An expressed sequence tag (EST) gene discovery strategy known as ORESTES has been employed to identify transcripts that might be involved in snail-schistosome interactions in order to examine gene expression patterns in infected B. glabrata. Over 3930 ESTs were sequenced from cDNA libraries made from both schistosome-exposed and unexposed snails using different tissue types, producing a database of 1843 non-redundant clones. The non-redundant set has been assessed for gene ontology and KEGG pathway assignments. This approach has revealed a number of signalling, antioxidant and immune-related gene homologues that, based on current understanding of molluscan and other comparative systems, might play an important role in the molluscan defence response towards infection.Entities:
Mesh:
Year: 2006 PMID: 17208299 PMCID: PMC1871615 DOI: 10.1016/j.dci.2006.11.004
Source DB: PubMed Journal: Dev Comp Immunol ISSN: 0145-305X Impact factor: 3.636
Biomphalaria glabrata ORESTES libraries. The number of non-redundant (NR) sequences was determined after cluster and Blast analyses to remove duplicate and ribosomal sequences from within each library
| Strain | Tissue | Parasite exposure | No. sequences obtained | % redundancy | No. NR sequences | % Unique (and non-ribo) | Library name |
|---|---|---|---|---|---|---|---|
| 1742 | HF | EX | 93 | 36.6 | 55 | 59.1 | BgORESTES infected NHM 1742 Head/foot |
| 1742 | HF | UN | 88 | 52.3 | 35 | 39.8 | BgORESTES uninfected NHM 1742 Head/foot |
| 1742 | OT | UN | 89 | 46.1 | 36 | 40.4 | BgORESTES uninfected NHM 1742 Ovotestis |
| 3017 | OT | EX | 94 | 50 | 45 | 47.9 | BgORESTES schistosome-exposed NHM 3017 Ovotestis |
| 1742 | OT | EX | 90 | 47.8 | 51 | 56.7 | BgORESTES infected NHM 1742 Ovotestis 1 |
| 1742 | OT | EX | 91 | 58.2 | 37 | 40.7 | BgORESTES infected NHM 1742 Ovotestis 2 |
| 1742 | HAEM | EX | 91 | 53.8 | 24 | 25.3 | BgORESTES infected NHM 1742 Haemocytes |
| 1742 | HO | UN | 92 | 51.1 | 42 | 45.7 | BgORESTES uninfected NHM 1742 Haemopoietic organ |
| 1742 | HO | EX | 96 | 56.3 | 36 | 37.5 | BgORESTES infected NHM 1742 Haemopoietic organ |
| 1742 | HAEM | UN | 92 | 58.7 | 24 | 26.1 | BgORESTES uninfected NHM 1742 Haemocytes |
| 3017 | HF | EX | 94 | 30.9 | 58 | 61.7 | BgORESTES schistosome-exposed NHM 3017 Head/foot |
| 3017 | OT | UN | 94 | 40.4 | 53 | 56.4 | BgORESTES unexposed NHM 3017 Ovotestis |
| 3017 | OT | EX | 93 | 40.9 | 52 | 55.9 | BgORESTES schistosome-exposed NHM 3017 Ovotestis2 |
| 3017 | HAEM | UN | 94 | 47.7 | 35 | 37.2 | BgORESTES unexposed NHM 3017 Haemocytes |
| 3017 | HAEM | EX | 87 | 57.5 | 20 | 23.0 | BgORESTES schistosome-exposed NHM 3017 Haemocytes |
| 3017 | HO | UN | 91 | 28.6 | 56 | 61.5 | BgORESTES unexposed NHM 3017 Haemopoietic organ |
| 3017 | HO | EX | 81 | 30.9 | 47 | 58.0 | BgORESTES schistosome-exposed NHM 3017 Haemopoietic organ |
| 3017 | HF | UN | 95 | 34.7 | 52 | 54.7 | BgORESTES unexposed NHM 3017 Head/foot |
| 3017 | HF | EX | 96 | 52.1 | 34 | 35.4 | BgORESTES schistosome-exposed NHM 3017 Head/foot2 |
| 3017 | HAEM | UN | 93 | 29 | 42 | 45.2 | BgORESTES unexposed NHM 3017 Haemocytes2 |
| 3017 | HAEM | EX | 90 | 70 | 9 | 10.0 | BgORESTES schistosome-exposed NHM 3017 Haemocytes2 |
| 3017 | HO | UN | 93 | 62.4 | 16 | 17.2 | BgORESTES unexposed NHM 3017 Haemopoietic organ2 |
| 3017 | HO | EX | 96 | 71.9 | 20 | 20.8 | BgORESTES schistosome-exposed NHM 3017 Haemopoietic organ2 |
| 3017 | OT | UN | 96 | 35.4 | 57 | 59.4 | BgORESTES unexposed NHM 3017 Ovotestis2 |
| 3017 | OT | EX | 94 | 45.7 | 47 | 50.0 | BgORESTES schistosome-exposed NHM 3017 Ovotestis3 |
| 3017 | HF | UN | 94 | 43.6 | 40 | 42.6 | BgORESTES unexposed NHM 3017 Head/foot2 |
| 3017 | HF | EX | 93 | 50.5 | 39 | 41.9 | BgORESTES schistosome-exposed NHM 3017 Head/foot3 |
| 1742 | B | UN | 95 | 20 | 66 | 69.5 | BgORESTES uninfected NHM 1742 Brain |
| 1742 | B | EX | 94 | 9.6 | 82 | 87.2 | BgORESTES infected NHM 1742 Brain |
| 3017 | B | UN | 91 | 71.4 | 18 | 19.8 | BgORESTES unexposed NHM 3017 Brain |
| 3017 | B | EX | 94 | 57.4 | 32 | 34.0 | BgORESTES schistosome-unexposed NHM 3017 Brain |
| 3032 | HF | EX | 95 | 51.6 | 43 | 45.3 | BgORESTES infected NHM 3032 Head/foot |
| 3032 | OT | EX | 94 | 46.8 | 47 | 50.0 | BgORESTES infected NHM 3032 Ovotestis |
| 3032 | B | EX | 94 | 42.6 | 49 | 52.1 | BgORESTES infected NHM 3032 Brain |
| 3032 | HO | EX | 96 | 36.5 | 56 | 58.3 | BgORESTES infected NHM 3032 Haemopoietic organ |
| 3032 | HAEM | UN | 95 | 24.2 | 64 | 67.4 | BgORESTES uninfected NHM 3032 Haemocytes |
| 3032 | HAEM | EX | 96 | 33.3 | 47 | 49.0 | BgORESTES infected NHM 3032 Haemocytes |
| 3032 | HF | UN | 93 | 36.6 | 59 | 63.4 | BgORESTES uninfected NHM 3032 Head/foot |
| 3032 | OT | UN | 94 | 19.1 | 74 | 78.7 | BgORESTES uninfected NHM 3032 Ovotestis |
| 3032 | B | UN | 95 | 23.2 | 73 | 76.8 | BgORESTES uninfected NHM 3032 Brain |
| 3032 | HO | UN | 93 | 16.1 | 71 | 76.3 | BgORESTES uninfected NHM 3032 Haemopoietic organ |
| Total | 3809 | 1843 | |||||
| Mean | 43.2 | 44.9 | 48.2 |
NHM Strain: 3017—resistant snails, 1742, 3032 (BB02)—susceptible snails.
Tissue type: HF—head/foot, OT—ovotestis, HO—haemopoietic organ, HAEM—haemocytes, B—brain.
Snails exposed (EX) or unexposed (UN) to S. mansoni miracidia.
Blast results summary. Breakdown of the types of sequences obtained from the B. glabrata ORESTES libraries identified with Blast searches of GenBank
| All sequences | Non-redundant sequences | |||
|---|---|---|---|---|
| Category | No. sequences | % sequences | No. sequences | % sequences |
| Protein | 907 | 23.8 | 739 | 40.1 |
| Mitochondrial Protein | 4 | 0.1 | 4 | 0.2 |
| Ribosomal Protein | 14 | 0.4 | 11 | 0.6 |
| 35 | 0.9 | 22 | 1.2 | |
| 41 | 1.1 | 40 | 2.2 | |
| Ribosomal | 1482 | 38.9 | 44 | 2.4 |
| Unknown (no BLAST match) | 1106 | 29.0 | 832 | 45.1 |
| Unknown EST | 84 | 2.2 | 56 | 3.0 |
| Unknown Protein | 127 | 3.3 | 88 | 4.8 |
| Other | 8 | 0.2 | 7 | 0.4 |
| Total | 3809 | 100.0 | 1843 | 100.0 |
Fig. 1Histogram showing EST clusters in the non-redundant EST set, after removal of duplicates within libraries.
Fig. 2Gene ontologies. Percentage representation of gene ontology (GO) mappings for B. glabrata ESTs. (a) Biological processes, (b) molecular function and (c) cellular component. Note that individual GO categories can have multiple mappings and that the charts do not include ESTs with no blast/gene ontology matches.
Transcripts selected by gene ontology. Individual B. glabrata ESTs that identified antioxidant proteins, signal transducers, transcription regulators and immune or stress response proteins
| Name | GenBank accession | Gene ID (Blast result) | Organism | Blast score |
|---|---|---|---|---|
| 3032HOUN59B8 | Peroxidasin (mKIAA0230) [BAC65505] | 2E-23 | ||
| 1742HFEX1H9 | Dual oxidase 1 [Q8HZK3] | 2E-31 | ||
| 3017OTEX4H6 | Putative iron dependent peroxidase [Q8XGB1] | 5E-15 | ||
| 1742OTEX5B12 | Putative iron dependent peroxidase [Q8XGB1] | 7E-11 | ||
| 3032HAEMEX55E1 | Peroxinectin [AAL05973] | 6E-17 | ||
| 3032BEX52G8 | Filamin 1 [P21333] | 5E-53 | ||
| 1742BUN46B6 | Adenylyl cyclase [Q9QW33] | 4E-78 | ||
| 3017OTUN34C11 | Ankyrin 2 (Brain ankyrin) [Q01484] | 2E-11 | ||
| 3017HFEX11B10 | Inhibitor of apoptosis protein [Q8UWD2] | 4E-17 | ||
| 3032OTUN57G6 | Inhibitor of apoptosis protein [Q8UWD2] | 4E-11 | ||
| 3017BEX49B1 | Buccalin precursor [P20481] | 5E-67 | ||
| 3032BEX52A2 | Buccalin precursor [P20481] | 2E-54 | ||
| 3032BEX52A12 | Buccalin precursor [P20481] | 2E-19 | ||
| 3032BUN58E5 | Buccalin precursor [P20481] | 5E-46 | ||
| 3032BUN58B9 | Buccalin precursor [P20481] | 2E-19 | ||
| 3032HAEMEX55A11 | cAMP-specific 3’,5’-cyclic phosphodiesterase [P12252] | 2E-31 | ||
| 3032OTUN57A5 | Serine/threonine-protein kinase TNNI3 K (ANK repeats) [Q7TQP6] | 1E-18 | ||
| 3032OTUN57B1 | Regulator of G-protein signalling 22 [Q9BYZ4] | 9E-22 | ||
| 3032HOUN59G3 | Bent (GH07636p) [Q9V4F7] | 2E-19 | ||
| 3032HOUN59B1 | Bent (GH07636p) [Q9V4F7] | 3E-76 | ||
| 3032HOEX53H6 | Elongation factor 1 alpha [P13549] | 1E-48 | ||
| 3017BUN48A11 | FMRFamide neuropeptides [P19802] | 4E-45 | ||
| 3032BUN58F5 | FMRFamide neuropeptides [P19802] | 1E-34 | ||
| 3017OTEX17H11 | Myotilin (Titin immunoglobulin domain protein) [Q9UBF9] | 8E-13 | ||
| 3017HAEMUN28C9 | Protein kinase C inhibitor 1 (14-3-3-like) [P35214] | 3E-52 | ||
| 3032HFEX50F2 | Hemolectin [Q9U5D0] | 2E-20 | ||
| 3032HFUN56E2 | Hemolectin [Q9U5D0] | 2E-20 | ||
| 3032HFUN56B8 | Hemolectin [Q9U5D0] | 4E-28 | ||
| 3017BEX49E3 | Molluscan insulin-related peptide 3 [P80090] | 6E-13 | ||
| 3032HFUN56E6 | Multiple EGF-like-domain protein 3 [O75095] | 1E-30 | ||
| 3032HFUN56F9 | Multiple EGF-like-domain protein 3 [O75095] | 8E-24 | ||
| 3032HOUN59C2 | Nidogen 1 [P10493] | 2E-23 | ||
| 3017HAEMEX19E1 | Feline leukemia virus subgroup C receptor [Q9N1F2] | 2E-28 | ||
| 3017HOUN20E11 | PERQ amino acid rich, with GYF domain 1 [Q99MR1] | 1E-23 | ||
| 3032HFEX50E11 | PERQ amino acid rich, with GYF domain 1 [Q99MR1] | 1E-20 | ||
| 3017HFUN44E6 | Polycystic kidney disease protein 2 [Q7Z2B5] | 9E-45 | ||
| 3032HOUN59B11 | Polydom protein precusor [Q9ES77] | 3E-12 | ||
| 3017HAEMUN28F10 | Polyserase 1B protein [Q7Z410] | 3E-22 | ||
| 3017HAEMEX29B4 | Polyserase 1B protein [Q7Z410] | 1E-22 | ||
| 3032BEX52E7 | Serine/threonine protein phosphatase 2A [P11493] | 4E-63 | ||
| 3032OTUN57F6 | pRb-interacting protein RbBP-36 [Q8IZZ0] | 1E-20 | ||
| 3032BEX52H9 | Tyrosine phosphatase IA-2beta [Q9Y4I9] | 6E-57 | ||
| 3032BUN58D5 | Tyrosine phosphatase IA-2beta [Q9Y4I9] | 2E-46 | ||
| 3032OTUN57B12 | Muscle M-line assembly protein UNC-89 [O01761] | 2E-12 | ||
| 3032HOUN59F4 | Muscle M-line assembly protein UNC-89 [O01761] | 8E-25 | ||
| 3032HOEX53B12 | Muscle M-line assembly protein UNC-89 [O01761] | 2E-20 | ||
| 1742HOUN8B5 | RAS related protein Rab21 [Q9UL25] | 3E-29 | ||
| 3017HFEX11H12 | RAS related protein Rab21 [Q9UL25] | 1E-29 | ||
| 1742HFEX1G2 | GTP-binding nuclear protein Ran [P79735] | 2E-80 | ||
| 3017OTUN34B9 | Serine/threonine protein kinase SSTK [Q9BXA6] | 3E-18 | ||
| 3032BUN58F11 | E3 ubiquitin-protein ligase HECTD1 [Q9ULT8] | 6E-66 | ||
| 3032HOEX53G8 | SNF4/AMP-activated protein kinase gamma subunit [O96613] | 2E-29 | ||
| 3017OTEX17B2 | Transportin-SR [Q9Y540] | 9E-58 | ||
| 1742HFEX1H2 | Twitchin [Q7YT99] | 5E-28 | ||
| 3017BUN48G6 | Type N4 regulatory subunit of protein kinase A [P31319] | 1E-50 | ||
| 3032OTUN57C10 | Testis-enriched protein tyrosine phosphatase [Q9WU22] | 2E-66 | ||
| 1742HAEMEX7G1 | Integrin alpha 3 [Q86G86] | 8E-23 | ||
| 3032OTUN57G7 | Receptor type protein-tyrosine phosphatase T precursor [O14522] | 3E-16 | ||
| 3017HAEMEX19A3 | G protein-coupled receptor kinase type 2 [Q9U756] | 3E-62 | ||
| 3017HFEX45B5 | Megalin [P98164] | 6E-20 | ||
| 1742OTEX5D3 | Activated protein kinase c receptor [Q9W7I1] | 1E-114 | ||
| 1742OTEX5H8 | Activated protein kinase c receptor [Q9W7I1] | 8E-24 | ||
| 3032HOUN59A5 | Receptor type guanylyl cyclase [Q9BPR0] | 1E-22 | ||
| 3032BUN58B3 | Soluble guanylyl cyclase alpha [Q7YW37] | 4E-63 | ||
| 1742HOEX9C10 | Collagen alpha 1(XIV) chain precusor (Undulin) [P32018] | 7E-15 | ||
| 1742BEX47A12 | JNK interacting protein 1 [Q9W0K0] | 4E-53 | ||
| 3032BUN58B11 | JNK interacting protein 1 [Q9W0K0] | 5E-31 | ||
| 1742BEX47E10 | JNK interacting protein 1 [Q9W0K0] | 2E-27 | ||
| 3032BUN58E4 | JNK interacting protein 1 [Q9W0K0] | 8E-24 | ||
| 3032BUN58A3 | Serine/threonine kinase receptor type1 [O73801] | 1E-57 | ||
| 3032HFEX50H7 | Plectin [Q15149] | 8E-15 | ||
| 3032HOEX53F1 | Smad anchor for receptor activation (SARA) [Q9YHB9] | 1E-56 | ||
| 3017HFEX11A5 | Src-family protein tyrosine kinase [Q8WQM5] | 4E-51 | ||
| 3032HAEMEX55D11 | TNF receptor-associated factor 1 [Q13077] | 2E-27 | ||
| 3017HFEX45B8 | Epidermal growth factor precusor [P01133] | 7E-22 | ||
| 3017HFEX45A4 | Fibrillin [P35555] | 8E-26 | ||
| 3017HOUN32A5 | Macrophage mannose receptor [Q61830] | 2E-14 | ||
| 3032HOEX53A1 | Macrophage mannose receptor [Q61830] | 9E-23 | ||
| 1742HOUN8F1 | CYR61 protein precursor [Q9ES72] | 4E-29 | ||
| 3017HAEMUN18E5 | Focal adhesion kinase [Q7Z1D3] | 1E-45 | ||
| 3032HAEMUN54B12 | Nicotinic acetylcholine receptor Dalpha6 [Q8T7S2] | 1E-49 | ||
| 1742HOEX9F4 | Afadin (AF-6 protein) [P55196] | 2E-18 | ||
| 3017HAEMUN18H12 | Glutamate Receptor 2 [Q10914] | 1E-15 | ||
| 3017HOUN20E9 | Bone morphogenetic protein 10 preproprotein [Q9R229] | 3E-30 | ||
| 3017HOEX21A5 | Bone morphogenetic protein 10 preproprotein [Q9R229] | 3E-30 | ||
| 3032HFUN56E10 | Clathrin heavy chain [P11442] | 1E-119 | ||
| 3032BEX52G5 | GABA Transaminase [P50554] | 1E-28 | ||
| 3032BUN58G12 | Cadherin-related tumour suppressor [Q14517] | 4E-28 | ||
| 3017HFEX45B11 | Guanylate kinase associated protein [O14490] | 4E-22 | ||
| 1742BUN46F12 | Guanylate kinase associated protein [O14490] | 4E-21 | ||
| 3032HOUN59G12 | Synaptojanin 2 [O15056] | 5E-13 | ||
| 1742BUN46H8 | Kinesin-like protein KIF1A [Q12756] | 3E-30 | ||
| 1742BUN46F1 | Kinesin-like protein KIF1B [Q8R524] | 1E-108 | ||
| 1742HFEX1H4 | Lethal giant larvae homolog 1 [O00188] | 7E-43 | ||
| 1742BUN46E9 | Prohormone convertase 2 (LPC2) [Q25409] | 1E-128 | ||
| 3032BUN58A9 | Munc13-2 protein [Q62769] | 1E-16 | ||
| 3017HFEX45B3 | Munc13-2 protein [Q62769] | 3E-39 | ||
| 1742HOEX9G9 | Sodium/potassium-transporting ATPase alpha-1 chain [Q9DGL6] | 6E-81 | ||
| 3017BEX49D12 | Synaptotagmin 11 [O08835] | 9E-50 | ||
| 3017BUN48C2 | Synaptotagmin 11 [O08835] | 3E-33 | ||
| 3032BUN58D7 | Synaptotagmin 11 [O08835] | 4E-34 | ||
| 3032OTUN57B8 | Tyrosine-protein kinase receptor [Q06807] | 6E-61 | ||
| 3032BUN58C12 | Putative pyrokinin receptor [Q7RTK4] | 5E-26 | ||
| 1742BEX47H10 | Tryptophan hydroxylase [Q9NJQ3] | 6E-41 | ||
| 3032BUN58D3 | Tryptophan hydroxylase [Q9NJQ3] | 1E-40 | ||
| 3017BEX49A4 | Eukaryotic translation intiation factor 3 subunit 10 [Q8I5S6] | 2E-21 | ||
| 3017OTEX17B6 | Calreticulin [Q26268] | 2E-63 | ||
| 1742HFEX1G4 | Chromodomain helicase DNA binding protein 5 [Q8TDI0] | 7E-55 | ||
| 3017OTEX17C2 | C-terminal binding protein [O46036] | 1E-79 | ||
| 1742HOUN8D7 | Cytochrome P450 monooxygenase [O04892] | 7E-21 | ||
| 1742HAEMUN10F7 | Cytochrome P450 monooxygenase [O04892] | 4E-17 | ||
| 1742HOUN8F12 | Cytochrome P450 monooxygenase [O04892] | 3E-15 | ||
| 3017HFEX45H10 | Elongation factor-2 [P13639] | 3E-49 | ||
| 3017OTUN16F11 | Embryonic ectoderm development protein [P97462] | 2E-51 | ||
| 3032OTUN57E7 | HemK methyltransferase family member [Q9Y5R4] | 3E-30 | ||
| 3017OTUN34G10 | High mobility group protein [P40618] | 2E-11 | ||
| 1742OTEX5D12 | Homeodomain interacting protein kinase 2 [Q9H2×6] | 1E-57 | ||
| 3017OTEX17A8 | Fragile-chorion membrane protein [P13709] | 6E-27 | ||
| 1742BUN46A9 | LIM domain protein BX (BEADEX protein). [P91608] | 2E-60 | ||
| 1742BEX47F11 | LIM domain protein BX (BEADEX protein). [P91608] | 1E-60 | ||
| 3017HFEX45E11 | Max dimerization protein 1; mad [Q05195] | 7E-24 | ||
| 3032OTUN57C3 | Myeloid/lymphoid or mixed-lineage leukemia protein 2 [O14686] | 4E-59 | ||
| 3017HAEMUN28B11 | Bifunctional aminoacyl-tRNA synthetase [P28668] | 2E-56 | ||
| 3017OTUN16C3 | Nuclear factor NF-kB1 [P25799] | 1E-17 | ||
| 3017HFUN44C3 | LReO_3 protein [Q8UUM8] | 4E-16 | ||
| 3032HOEX53E9 | LReO_3 protein [Q8UUM8] | 1E-18 | ||
| 3032HFEX50B11 | LReO_3 protein [Q8UUM8] | 2E-18 | ||
| 1742HOUN8F2 | LReO_3 protein [Q8UUM8] | 2E-31 | ||
| 3017OTEX35D8 | Transcriptional activator protein Pur-alpha [P42669] | 7E-31 | ||
| 1742HAEMUN10D9 | Retinoblastoma binding protein 5 [Q15291] | 1E-61 | ||
| 3032HFEX50F6 | Smad4 type2 [Q9W639] | 7E-76 | ||
| 1742HAEMEX7F10 | Transcription elongation factor DSIF [O00267] | 1E-94 | ||
| 3017HOUN32D1 | Transcription elongation factor DSIF [O00267] | 8E-32 | ||
| 3032HOEX53F10 | RUSH-1 [Q95216] | 9E-68 | ||
| 1742HFEX1H6 | Tis11 family protein [P47974] | 3E-36 | ||
| 3017HOEX33B8 | Transcription factor IID p80 chain homolog [Q91857] | 2E-55 | ||
| 1742HFEX1C3 | Tropomyosin [O97192] | 6E-39 | ||
| 3017HOEX21A2 | Tropomyosin [O97192] | 1E-40 | ||
| 3017HFUN44E7 | Tropomyosin [O97192] | 7E-77 | ||
| 3032HAEMUN54H4 | Staphylococcal nuclease domain-containing protein 1 [Q7K2F4] | 3E-26 | ||
| 3032HAEMUN54E4 | Winged-helix repressor FOXP4 [Q8CIS1] | 3E-12 | ||
| 3032HAEMUN54C3 | Jumonji domain containing protein 2C [Q9H3R0] | 5E-73 | ||
| 1742OTEX5C1 | WDR9protein [Q9NSI6] | 1E-80 | ||
| 3017HFEX11G11 | Pliotropic regulator 1 [Q9WUC8] | 2E-29 | ||
| 1742BUN46G3 | Transcriptional regulator ATRX protein [P46100] | 7E-90 | ||
| 1742BEX47D9 | Beta-catenin [P35224] | 2E-34 | ||
| 3032HOEX53H9 | Beta-catenin [P35224] | 2E-83 | ||
| 1742BUN46H7 | Fibropellin-1 [P10079] | 1E-17 | ||
| 3032OTUN57B7 | HIRA protein [P54198] | 3E-68 | ||
| 1742OTEX5A12 | IKAP [O95163] | 4E-41 | ||
| 1742HFUN2A2 | Nuclear hormone receptor FTZ-F1 beta [Q05192] | 2E-17 | ||
| 3032HOUN59B7 | Orphan nuclear receptor NR1D2 [Q14995] | 4E-25 | ||
| 1742OTEX5C2 | Histone-binding protein RBBP4 [Q09028] | 1E-131 | ||
| 3032BUN58C5 | Alpha 2-macroglobulin [O01717] | 5E-20 | ||
| 1742OTEX6D7 | Alpha-1 inhibitor III [Q62591] | 3E-16 | ||
| 1742BEX47H4 | ATP-binding cassette sub-family F member 1 [Q8NE71] | 5E-56 | ||
| 1742HOUN8H9 | Paramyosin [O96064] | 7E-61 | ||
| 3017OTUN16E12 | Exosome complex exonuclease RRP45 [Q9JHI7] | 5E-73 | ||
| 3032BEX52B6 | Exosome complex exonuclease RRP45 [Q9JHI7] | 2E-77 | ||
| 1742OTUN3F6 | J kappa-recombination signal binding protein [P31266] | 2E-24 | ||
| 3017OTUN34C5 | Rho guanine nucleotide exchange factor 4 [Q9NR80] | 4E-36 | ||
| 1742BEX47G7 | Soma ferritin [P42577] | 7E-60 | ||
| 3032HFUN56G3 | Soma ferritin [P42577] | 3E-59 | ||
| 3017HOUN20F4 | 60S acidic ribosomal protein P0 [Q9NHP0] | 9E-73 | ||
| 1742HOEX9H9 | Cdc7-related kinase [Q9Z2Y5] | 4E-45 | ||
| 3032HAEMUN54A6 | ATP-dependent RNA helicase Ddx1 [Q9VNV3] | 1E-60 | ||
| 3017OTUN34C6 | 78 kDa glucose-regulated protein precursor [Q16956] | 2E-86 | ||
| 3017BUN48H5 | Helicase-like protein NHL [Q9NZ71] | 1E-25 | ||
| 3032OTUN57E6 | Hypoxia up-regulated 1 [Q9Y4L1] | 1E-38 | ||
| 3032HOEX53A9 | Mismatch repair protein pms1 homologue [Q8IBJ3] | 1E-14 | ||
| 3017HOEX33D3 | DNA mismatch repair protein Mlh1 [P40692] | 2E-25 | ||
| 1742OTEX6D1 | Polyubiquitin [P62988] | 2E-55 | ||
| 3017OTUN34G6 | Polyubiquitin [P62988] | 6E-85 | ||
| 1742HOUN8C5 | Polyubiquitin [P62988] | 8E-44 | ||
GenBank accession number, organism and E value given for the top match.
KEGG pathways identified by B. glabrata ESTs
| KEGG categories represented | Enzymes | Clones | |
|---|---|---|---|
| 1 | |||
| 1.1 | |||
| 1.1.1 | Glycolysis/gluconeogenesis | 7 | 12 |
| 1.1.3 | Pentose phosphate pathway | 4 | 5 |
| 1.1.5 | Fructose and mannose metabolism | 1 | 2 |
| 1.1.6 | Galactose metabolism | 2 | 2 |
| 1.1.7 | Ascorbate and aldarate metabolism | 3 | 4 |
| 1.1.8 | Starch and sucrose metabolism | 6 | 12 |
| 1.1.9 | Aminosugars metabolism | 1 | 1 |
| 1.1.11 | Pyruvate metabolism | 4 | 5 |
| 1.1.12 | Glyoxylate and dicarboxylate metabolism | 1 | 1 |
| 1.1.13 | Propanoate metabolism | 2 | 2 |
| 1.1.14 | Butanoate metabolism | 5 | 5 |
| 1.1.17 | Inositol phosphate metabolism | 1 | 1 |
| 1.2 | |||
| 1.2.1 | Oxidative phosphorylation | 7 | 7 |
| 1.2.2 | ATP synthesis | 1 | 1 |
| 1.2.4 | Carbon fixation | 3 | 7 |
| 1.2.6 | Methane metabolism | 2 | 2 |
| 1.2.7 | Nitrogen metabolism | 1 | 1 |
| 1.3 | |||
| 1.3.1 | Fatty acid biosynthesis | 1 | 1 |
| 1.3.2 | Fatty acid elongation in mitochondria | 1 | 2 |
| 1.3.3 | Fatty acid metabolism | 2 | 2 |
| 1.3.4 | Synthesis and degradation of ketone bodies | 1 | 1 |
| 1.3.6 | Bile acid biosynthesis | 1 | 1 |
| 1.3.9 | Glycerolipid metabolism | 1 | 1 |
| 1.3.10 | Glycerophospholipid metabolism | 2 | 2 |
| 1.4 | |||
| 1.4.1 | Purine metabolism | 6 | 8 |
| 1.4.2 | Pyrimidine metabolism | 3 | 4 |
| 1.5 | |||
| 1.5.1 | Glutamate metabolism | 2 | 2 |
| 1.5.2 | Alanine and aspartate metabolism | 1 | 1 |
| 1.5.3 | Glycine, serine and threonine metabolism | 4 | 6 |
| 1.5.4 | Methionine metabolism | 1 | 2 |
| 1.5.6 | Valine, leucine and isoleucine degradation | 2 | 2 |
| 1.5.7 | Valine, leucine and isoleucine biosynthesis | 2 | 3 |
| 1.5.8 | Lysine biosynthesis | 1 | 1 |
| 1.5.9 | Lysine degradation | 2 | 2 |
| 1.5.10 | Arginine and proline metabolism | 5 | 7 |
| 1.5.11 | Histidine metabolism | 2 | 3 |
| 1.5.12 | Tyrosine metabolism | 2 | 3 |
| 1.5.13 | Phenylalanine metabolism | 2 | 2 |
| 1.5.14 | Tryptophan metabolism | 5 | 6 |
| 1.5.15 | Phenylalanine, tyrosine and tryptophan biosynthesis | 2 | 3 |
| 1.5.16 | Urea cycle and metabolism of amino groups | 3 | 4 |
| 1.6 | |||
| 1.6.1 | 3 | 4 | |
| 1.6.3 | Aminophosphonate metabolism | 1 | 2 |
| 1.6.4 | Selenoamino acid metabolism | 1 | 2 |
| 1.7 | |||
| 1.7.1 | 1 | 1 | |
| 1.7.3 | 1 | 1 | |
| 1.7.4 | 1 | 1 | |
| 1.7.12 | Glycosphingolipid metabolism | 1 | 1 |
| 1.8 | |||
| 1.8.3 | Biosynthesis of ansamycins | 1 | 1 |
| 1.9 | |||
| 1.9.3 | Vitamin B6 metabolism | 2 | 2 |
| 1.9.6 | Biotin metabolism | 1 | 1 |
| 1.9.7 | Folate biosynthesis | 3 | 8 |
| 1.9.10 | Porphyrin and chlorophyll metabolism | 3 | 4 |
| 1.9.11 | Ubiquinone biosynthesis | 4 | 4 |
| 1.10 | |||
| 1.10.4 | Limonene and pinene degradation | 2 | 2 |
| 1.10.6 | Stilbene, coumarine and lignin biosynthesis | 3 | 4 |
| 1.10.8 | Alkaloid biosynthesis I | 1 | 2 |
| 1.10.12 | Streptomycin biosynthesis | 1 | 1 |
| 1.11 | |||
| 1.11.4 | 2 | 2 | |
| 1.11.5 | 3-chloroacrylic acid degradation | 1 | 2 |
| 1.11.6 | 1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation | 1 | 2 |
| 1.11.8 | 1,2-dichloroethane degradation | 1 | 1 |
| 1.11.14 | Fluorene degradation | 2 | 3 |
| 1.11.17 | Benzoate degradation via hydroxylation | 1 | 2 |
| 1.11.18 | Atrazine degradation | 1 | 1 |
| 1.11.20 | 1- and 2-methylnaphthalene degradation | 1 | 2 |
| 2 | |||
| 2.1 | |||
| 2.1.2 | RNA polymerase | 1 | 1 |
| 2.1.3 | Basal transcription factors | 2 | 2 |
| 2.2 | |||
| 2.2.2 | Ribosome | 20 | 27 |
| 2.2.3 | Aminoacyl-tRNA biosynthesis | 16 | 35 |
| 2.3 | |||
| 2.3.1 | Protein export | 2 | 3 |
| 2.3.2 | Type II secretion system | 1 | 1 |
| 2.3.7 | Ubiquitin mediated proteolysis | 3 | 4 |
| 2.3.8 | Proteasome | 7 | 11 |
| 3 | |||
| 3.1 | |||
| 3.1.1 | ABC transporters | 15 | 23 |
| 3.2 | |||
| 3.2.1 | Two-component system | 3 | 3 |
| 3.2.2 | MAPK signalling pathway | 4 | 7 |
| 3.2.3 | Wnt signalling pathway | 6 | 6 |
| 3.2.4 | Notch signalling pathway | 1 | 1 |
| 3.2.6 | TGF- | 5 | 5 |
| 3.2.9 | Calcium signalling pathway | 10 | 14 |
| 3.2.10 | Phosphatidylinositol signalling system | 2 | 2 |
| 3.3 | |||
| 3.3.1 | Neuroactive ligand–receptor interaction | 17 | 20 |
| 3.3.2 | Cytokine–cytokine receptor interaction | 3 | 3 |
| 3.3.3 | ECM–receptor interaction | 5 | 7 |
| 3.3.4 | Cell adhesion molecules (CAMs) | 25 | 36 |
| 4 | |||
| 4.1 | |||
| 4.1.3 | Regulation of actin cytoskeleton | 15 | 37 |
| 4.2 | |||
| 4.2.1 | Cell cycle | 5 | 5 |
| 4.2.2 | Apoptosis | 6 | 11 |
| 4.3 | |||
| 4.3.1 | Focal adhesion | 13 | 26 |
| 4.3.2 | Adherens junction | 8 | 16 |
| 4.3.3 | Tight junction | 9 | 21 |
| 4.3.4 | Gap junction | 6 | 25 |
| 4.4 | |||
| 4.4.1 | Insulin signalling pathway | 6 | 8 |
| 4.4.2 | Adipocytokine signalling pathway | 3 | 3 |
| 4.5 | |||
| 4.5.1 | Hematopoietic cell lineage | 2 | 2 |
| 4.5.2 | Complement and coagulation cascades | 5 | 7 |
| 4.5.3 | Toll-like receptor signalling pathway | 1 | 1 |
| 4.5.4 | Natural killer cell mediated cytotoxicity | 2 | 2 |
| 4.5.6 | T cell receptor signalling pathway | 2 | 2 |
| 4.5.7 | B cell receptor signalling pathway | 6 | 7 |
| 4.5.9 | Leukocyte transendothelial migration | 7 | 10 |
| 4.8 | |||
| 4.8.2 | Axon guidance | 7 | 10 |
| 4.9 | |||
| 4.9.1 | Circadian rhythm | 3 | 7 |
Enzymes—the number of enzymes from each pathway that were identified.
Clones—the number of ORESTES clones that identified enzymes.
Summary of KEGG pathways identified by B. glabrata ESTs
| Pathways represented | Total possible | Enzymes identified | No. EST clones | ||
|---|---|---|---|---|---|
| 1.1 | Carbohydrate metabolism | 13 | 17 | 37 | 52 |
| 1.2 | Energy metabolism | 5 | 8 | 14 | 18 |
| 1.3 | Lipid metabolism | 7 | 12 | 9 | 10 |
| 1.4 | Nucleotide metabolism | 2 | 2 | 9 | 12 |
| 1.5 | Amino acid metabolism | 15 | 16 | 36 | 47 |
| 1.6 | Metabolism of other amino acids | 3 | 9 | 5 | 8 |
| 1.7 | Glycan biosynthesis and metabolism | 4 | 19 | 4 | 4 |
| 1.8 | Biosynthesis of polyketides and nonribosomal peptides | 1 | 9 | 1 | 1 |
| 1.9 | Metabolism of cofactors and vitamins | 5 | 11 | 13 | 19 |
| 1.10 | Biosynthesis of secondary metabolites | 4 | 16 | 7 | 9 |
| 1.11 | Biodegradation of xenobiotics | 8 | 21 | 10 | 15 |
| 67 | 140 | 145 | 195 | ||
| 2.1 | Transcription | 2 | 3 | 3 | 3 |
| 2.2 | Translation | 2 | 3 | 36 | 62 |
| 2.3 | Folding, sorting and degradation | 4 | 8 | 13 | 19 |
| 2.4 | Replication and repair | 0 | 1 | 0 | 0 |
| 8 | 15 | 52 | 84 | ||
| 3.1 | Membrane transport | 1 | 2 | 15 | 23 |
| 3.2 | Signal transduction | 7 | 11 | 31 | 38 |
| 3.3 | Signalling molecules and interaction | 4 | 4 | 50 | 66 |
| 12 | 17 | 96 | 127 | ||
| 4.1 | Cell motility | 1 | 3 | 15 | 37 |
| 4.2 | Cell growth and death | 2 | 2 | 11 | 16 |
| 4.3 | Cell communication | 4 | 4 | 36 | 88 |
| 4.4 | Endocrine system | 2 | 3 | 9 | 11 |
| 4.5 | Immune system | 7 | 9 | 25 | 31 |
| 4.6 | Nervous system | 0 | 2 | 0 | 0 |
| 4.7 | Sensory system | 0 | 2 | 0 | 0 |
| 4.8 | Development | 1 | 2 | 7 | 10 |
| 4.9 | Behaviour | 1 | 1 | 3 | 7 |
| 18 | 28 | 106 | 200 | ||